Parkwood LLC decreased its stake in HCP Inc. (NYSE:HCP) by 14.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,928 shares of the real estate investment trust’s stock after selling 1,980 shares during the period. Parkwood LLC’s holdings in HCP were worth $422,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Glenmede Trust Co. NA raised its position in shares of HCP by 1.0% in the first quarter. Glenmede Trust Co. NA now owns 43,235 shares of the real estate investment trust’s stock valued at $1,407,000 after buying an additional 428 shares during the period. PGGM Investments raised its position in shares of HCP by 1.1% in the first quarter. PGGM Investments now owns 2,343,553 shares of the real estate investment trust’s stock valued at $76,353,000 after buying an additional 25,014 shares during the period. Saddle Road Partners LLC raised its position in shares of HCP by 26.6% in the first quarter. Saddle Road Partners LLC now owns 21,703 shares of the real estate investment trust’s stock valued at $707,000 after buying an additional 4,561 shares during the period. Ronna Sue Cohen raised its position in shares of HCP by 5.6% in the first quarter. Ronna Sue Cohen now owns 65,972 shares of the real estate investment trust’s stock valued at $2,149,000 after buying an additional 3,490 shares during the period. Finally, CrestPoint Capital Management LLC raised its position in shares of HCP by 26.0% in the first quarter. CrestPoint Capital Management LLC now owns 9,700 shares of the real estate investment trust’s stock valued at $316,000 after buying an additional 2,000 shares during the period. 91.16% of the stock is owned by hedge funds and other institutional investors.

Shares of HCP Inc. (NYSE:HCP) traded up 0.35% during mid-day trading on Friday, hitting $37.16. 4,296,804 shares of the company’s stock were exchanged. The firm has a 50 day moving average price of $39.10 and a 200-day moving average price of $35.37. HCP Inc. has a 52 week low of $25.11 and a 52 week high of $40.43. The company’s market capitalization is $17.38 billion.

HCP (NYSE:HCP) last issued its quarterly earnings data on Tuesday, August 9th. The real estate investment trust reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.04. The firm had revenue of $662.20 million for the quarter, compared to analyst estimates of $631.25 million. HCP had a negative net margin of 2.52% and a negative return on equity of 0.67%. The company’s revenue for the quarter was up 9.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.79 earnings per share. On average, equities analysts anticipate that HCP Inc. will post $2.83 EPS for the current year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, August 23rd. Stockholders of record on Monday, August 8th were given a $0.575 dividend. This represents a $2.30 dividend on an annualized basis and a dividend yield of 6.19%. The ex-dividend date of this dividend was Thursday, August 4th. HCP’s dividend payout ratio is -1,533.33%.

HCP has been the subject of several research reports. Citigroup Inc. boosted their price objective on shares of HCP from $34.00 to $38.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 24th. BTIG Research initiated coverage on shares of HCP in a research note on Thursday, August 25th. They set a “neutral” rating for the company. Wells Fargo & Co. reiterated a “hold” rating on shares of HCP in a research note on Sunday, September 4th. Raymond James Financial Inc. initiated coverage on shares of HCP in a research note on Tuesday, July 26th. They set an “underperform” rating for the company. Finally, Mizuho boosted their price objective on shares of HCP from $32.00 to $37.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 10th. Seven research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $34.24.

In other news, insider Darren A. Kowalske sold 2,250 shares of HCP stock in a transaction that occurred on Wednesday, August 31st. The shares were sold at an average price of $39.20, for a total value of $88,200.00. Following the transaction, the insider now owns 9,793 shares of the company’s stock, valued at $383,885.60. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Thomas D. Kirby sold 3,000 shares of HCP stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $40.24, for a total transaction of $120,720.00. The disclosure for this sale can be found here. 0.22% of the stock is currently owned by insiders.

HCP Company Profile

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

5 Day Chart for NYSE:HCP

Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP Inc. (NYSE:HCP).

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.